CIK 0001446159 · Non-accelerated filer<br>Smaller reporting company
AXE COMPUTE INC.
Sign in to watch- Ticker
- AGPU
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 331007393
- Phone
- 305-563-3850
- Business address
- 801 BRICKELL AVENUE, SUITE 510, MIAMI, FL, 33131
- Former names
- Predictive Oncology Inc., Precision Therapeutics Inc., Skyline Medical Inc., BioDrain Medical, Inc.
- Open-market buys, last 90 days
- $98,325
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$98,325. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-24 | Schwartz Carl I. Chief Executive Officer | Other acquisition | +100,401 | $1.43 | $144K | 1,711,742 |
| 2020-12-31 | ST. CLAIR GREGORY SR Director | Grant or award · Stock Options (right to buy) | +20,481 | 20,481 | ||
| 2020-12-31 | Nuzum Charles Lee Sr Director | Grant or award · Stock Options (right to buy) | +34,135 | 34,135 | ||
| 2020-12-31 | GABRIEL RICHARD L Director | Grant or award · Stock options (right to buy) | +20,481 | 20,481 | ||
| 2020-12-31 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (right to buy) | +20,481 | 20,481 | ||
| 2020-12-31 | ENGLE J MELVILLE Director | Grant or award · Stock Options (right to buy) | +47,788 | 47,788 | ||
| 2020-12-31 | CHUNG-WELCH NANCY Director | Grant or award · Stock Options (right to buy) | +34,135 | 34,135 | ||
| 2020-12-31 | HANDLEY DANIEL E Director | Grant or award · Stock Options (right to buy) | +20,481 | 20,481 | ||
| 2020-10-22 | Schwartz Carl I. Chief Executive Officer | Sale | −640 | $0.85 | $544 | 1,611,341 |
| 2020-09-30 | HANDLEY DANIEL E Director | Grant or award · Stock Options (right to buy) | +6,142 | 6,142 | ||
| 2020-09-30 | ENGLE J MELVILLE Director | Grant or award · Stock Options (right to buy) | +6,142 | 6,142 | ||
| 2020-09-30 | CHUNG-WELCH NANCY Director | Grant or award · Stock Options (right to buy) | +6,142 | 6,142 | ||
| 2020-09-30 | Nuzum Charles Lee Sr Director | Grant or award · Stock Options (right to buy) | +6,142 | 6,142 | ||
| 2020-09-30 | ST. CLAIR GREGORY SR Director | Grant or award · Stock Options (right to buy) | +6,142 | 6,142 | ||
| 2020-09-30 | GABRIEL RICHARD L Director | Grant or award · Stock options (right to buy) | +6,142 | 6,142 | ||
| 2020-09-30 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (right to buy) | +6,142 | 6,142 | ||
| 2020-09-23 | MYERS ROBERT L Chief Financial Officer | Grant or award · Restricted Stock Units | +100,000 | 100,000 | ||
| 2020-09-23 | Schwartz Carl I. Chief Executive Officer | Grant or award · Restricted Stock Units | +300,000 | 300,000 | ||
| 2020-09-04 | MYERS ROBERT L Chief Financial Officer | Returned to the company · Stock Options | −53 | 0 | ||
| 2020-09-04 | MYERS ROBERT L Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +53 | 53 |
Page 8 of 20 · 384 trades